top of page
DC.jpg

IN THE STATES

WASHINGTON, D.C.

The economic footprint of the biopharmaceutical industry can be measured by traditional indicators of employment and output, and its impact on the vendors, large and small, that provide services or supplies to America's biopharmaceutical research companies. The data below illustrates jobs, economic impact and clinical trial data for the industry as a whole, and vendor/supplier data from 15 major biopharmaceutical companies regarding their business relationships and total expenditures paid to vendors in Washington, D.C. in 2022.

DC.png

Download vendor data for Washington, D.C.:

Economic
Output

$2.8B

Direct Jobs Supported by the Industry

3,809

Total Jobs Supported

8,359

State Total Vendor Relationships

949

State Total Vendor Spending

$560,133,730

Clinical
Trials

294

Investments at Clinical Trial Sites

$63.3M

Clinical Trial Participants

4,433

Total Economic Impact of Clinical Trial Sites

$106.9M

bottom of page